| Primary |
| Product Used For Unknown Indication |
21.8% |
| Hepatic Cirrhosis |
14.5% |
| Drug Use For Unknown Indication |
12.2% |
| Hypoalbuminaemia |
8.0% |
| Ascites |
6.5% |
| Ischaemic Stroke |
4.6% |
| Hypertension |
4.2% |
| Peritonitis Bacterial |
3.8% |
| Haemorrhagic Disorder |
3.1% |
| Hepatic Function Abnormal |
2.3% |
| Immunosuppression |
2.3% |
| Iron Deficiency Anaemia |
2.3% |
| Sedation |
2.3% |
| Septic Shock |
2.3% |
| Coagulopathy |
1.9% |
| Hepatic Encephalopathy |
1.9% |
| Cirrhosis Alcoholic |
1.5% |
| Fluid Replacement |
1.5% |
| Generalised Oedema |
1.5% |
| Haemolytic Uraemic Syndrome |
1.5% |
|
| Tremor |
16.7% |
| Hepatitis C |
10.0% |
| Pulmonary Oedema |
9.2% |
| Sepsis |
7.5% |
| Feeling Abnormal |
5.8% |
| Respiratory Distress |
5.8% |
| Pyrexia |
5.0% |
| Brain Oedema |
4.2% |
| Transfusion-related Acute Lung Injury |
4.2% |
| Hepatitis B |
3.3% |
| Malaise |
3.3% |
| Pleural Effusion |
3.3% |
| Transmission Of An Infectious Agent Via A Medicinal Product |
3.3% |
| Urticaria |
3.3% |
| Dermatitis Exfoliative |
2.5% |
| Erythema |
2.5% |
| Hepatitis C Rna Positive |
2.5% |
| Infusion Related Reaction |
2.5% |
| Medication Error |
2.5% |
| Respiratory Arrest |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
23.9% |
| Psoriatic Arthropathy |
12.1% |
| Drug Use For Unknown Indication |
11.8% |
| Prophylaxis |
10.5% |
| Hypertension |
4.9% |
| Ascites |
3.8% |
| Hepatic Cirrhosis |
3.2% |
| Hypoalbuminaemia |
3.2% |
| Antipyresis |
2.8% |
| Iron Deficiency Anaemia |
2.8% |
| Infection |
2.7% |
| Insomnia |
2.7% |
| Cholestasis |
2.2% |
| Drug Therapy |
2.1% |
| Constipation |
2.0% |
| Hepatorenal Syndrome |
2.0% |
| Hypovolaemic Shock |
2.0% |
| Nutritional Support |
2.0% |
| Hepatitis C |
1.9% |
| Convulsion Prophylaxis |
1.7% |
|
| Hepatitis C |
15.9% |
| Erythema |
13.4% |
| Dermatitis Exfoliative |
9.6% |
| Tremor |
9.6% |
| Histiocytosis Haematophagic |
6.4% |
| Transmission Of An Infectious Agent Via A Medicinal Product |
5.7% |
| Stevens-johnson Syndrome |
5.1% |
| Thrombotic Microangiopathy |
4.5% |
| Toxic Epidermal Necrolysis |
4.5% |
| Infection |
3.2% |
| Liver Disorder |
3.2% |
| Feeling Abnormal |
2.5% |
| Pulmonary Congestion |
2.5% |
| Tumour Lysis Syndrome |
2.5% |
| Blood Pressure Decreased |
1.9% |
| Bronchospasm |
1.9% |
| Hepatitis B |
1.9% |
| Hepatitis B Surface Antigen Positive |
1.9% |
| Pruritus |
1.9% |
| Rash |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.7% |
| Drug Use For Unknown Indication |
19.1% |
| Prophylaxis |
6.9% |
| Sedation |
3.7% |
| Fluid Replacement |
3.7% |
| Infection |
3.3% |
| Hypertension |
2.7% |
| Coronary Artery Bypass |
2.6% |
| Infection Prophylaxis |
2.4% |
| Ureteral Stent Insertion |
2.4% |
| Ureteral Stent Removal |
2.4% |
| Surgery |
1.8% |
| Pyrexia |
1.8% |
| Insomnia |
1.7% |
| Diuretic Therapy |
1.7% |
| Abdominal Pain |
1.6% |
| Hypoalbuminaemia |
1.5% |
| Pain |
1.5% |
| Prophylaxis Against Graft Versus Host Disease |
1.3% |
| Anticoagulant Therapy |
1.2% |
|
| Sepsis |
8.7% |
| Respiratory Failure |
8.6% |
| Renal Failure |
8.5% |
| Injury |
7.7% |
| Unevaluable Event |
7.6% |
| Pain |
7.4% |
| White Blood Cell Count Decreased |
6.2% |
| Thrombocytopenia |
5.1% |
| Vomiting |
5.0% |
| Anxiety |
4.9% |
| Fear |
4.6% |
| Renal Failure Acute |
4.3% |
| Anhedonia |
3.8% |
| Septic Shock |
3.5% |
| Emotional Distress |
2.7% |
| Pneumonia |
2.6% |
| Renal Impairment |
2.6% |
| Depression |
2.3% |
| Multi-organ Failure |
2.0% |
| Staphylococcal Sepsis |
1.9% |
|
